Innovation

Oncogene CoAA as a Diagnostic Marker for Human Cancers

Medical College of Georgia
posted on 09/03/2010

Current State of the art: The present diagnostic methods for human cancer are with imaging, clinical blood work, and some forms of marker identification, i.e. BRCA1/2. Problems with the current art: The present set of diagnostic markers used in identifying cancers are limited and their presence may not always be conclusive of cancer without further tests such as imaging. Advantages of the novel invention: The novel invention identifies a new genetic loci that can be used as an additional diagnostic marker for the identification of human cancers.


Innovation Details
 

File Number: MCG 2007-010 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Kourosh Sabet-Payman at Medical College of Georgia for more information.

Request more info via email request more info
People

Case Manager:

Kourosh Sabet-Payman Kourosh Sabet-Payman

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
8081

Medical College of Georgia


Profile
Related Tags

Find more innovations

February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...